These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 30389154)
1. Modulation of hypersensitivity to oxidative DNA damage in ATM defective cells induced by potassium bromate by inhibition of the Poly (ADP-ribose) polymerase (PARP). Mosesso P; Piane M; Pepe G; Cinelli S; Chessa L Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt A):117-123. PubMed ID: 30389154 [TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-Ribose) Polymerase-1 inhibition potentiates cell death and phosphorylation of DNA damage response proteins in oxidative stressed retinal cells. Martín-Guerrero SM; Casado P; Muñoz-Gámez JA; Carrasco MC; Navascués J; Cuadros MA; López-Giménez JF; Cutillas PR; Martín-Oliva D Exp Eye Res; 2019 Nov; 188():107790. PubMed ID: 31494107 [TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) polymerase activity is not affected in ataxia telangiectasia cells and knockout mice. Dantzer F; Ménissier-de Murcia J; Barlow C; Wynshaw-Boris A; de Murcia G Carcinogenesis; 1999 Jan; 20(1):177-80. PubMed ID: 9934867 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair. Bryant HE; Helleday T Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909 [TBL] [Abstract][Full Text] [Related]
6. Ataxia-telangiectasia mutated and ataxia telangiectasia and Rad3-related kinases as therapeutic targets and stratification indicators for prostate cancer. Gulliver C; Hoffmann R; Baillie GS Int J Biochem Cell Biol; 2022 Jun; 147():106230. PubMed ID: 35609768 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks. Golla RM; Li M; Shen Y; Ji M; Yan Y; Fu K; Greiner TC; McKeithan TW; Chan WC Hematol Oncol; 2012 Dec; 30(4):175-9. PubMed ID: 22170260 [TBL] [Abstract][Full Text] [Related]
8. 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells. Hong R; Ma F; Zhang W; Yu X; Li Q; Luo Y; Zhu C; Jiang W; Xu B BMC Cancer; 2016 Sep; 16(1):725. PubMed ID: 27613518 [TBL] [Abstract][Full Text] [Related]
9. Interaction between ATM and PARP-1 in response to DNA damage and sensitization of ATM deficient cells through PARP inhibition. Aguilar-Quesada R; Muñoz-Gámez JA; Martín-Oliva D; Peralta A; Valenzuela MT; Matínez-Romero R; Quiles-Pérez R; Menissier-de Murcia J; de Murcia G; Ruiz de Almodóvar M; Oliver FJ BMC Mol Biol; 2007 Apr; 8():29. PubMed ID: 17459151 [TBL] [Abstract][Full Text] [Related]
10. PARP inhibition induces Akt-mediated cytoprotective effects through the formation of a mitochondria-targeted phospho-ATM-NEMO-Akt-mTOR signalosome. Tapodi A; Bognar Z; Szabo C; Gallyas F; Sumegi B; Hocsak E Biochem Pharmacol; 2019 Apr; 162():98-108. PubMed ID: 30296409 [TBL] [Abstract][Full Text] [Related]
11. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1. Yoon JH; Ahn SG; Lee BH; Jung SH; Oh SH Biochem Pharmacol; 2012 Mar; 83(6):747-57. PubMed ID: 22226932 [TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders. Henning RJ; Bourgeois M; Harbison RD Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072 [TBL] [Abstract][Full Text] [Related]
13. Ataxia telangiectasia: G2 checkpoint and chromosomal damage in proliferating lymphocytes. Pincheira J; Bravo M; Navarrete MH; Marcelain K; López-Sáez JF; de la Torre C Mutagenesis; 2001 Sep; 16(5):419-22. PubMed ID: 11507241 [TBL] [Abstract][Full Text] [Related]
14. Modulation of chromatin conformation by the histone deacetylase inhibitor trichostatin A promotes the removal of radiation-induced lesions in ataxia telangiectasia cell lines. Egidi A; Filippi S; Manganello F; Lopez-Martinez W; Meschini R Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt A):109-116. PubMed ID: 30389153 [TBL] [Abstract][Full Text] [Related]
15. ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition. Gilardini Montani MS; Prodosmo A; Stagni V; Merli D; Monteonofrio L; Gatti V; Gentileschi MP; Barilà D; Soddu S J Exp Clin Cancer Res; 2013 Nov; 32(1):95. PubMed ID: 24252502 [TBL] [Abstract][Full Text] [Related]
16. Correction of ATM mutations in iPS cells from two ataxia-telangiectasia patients restores DNA damage and oxidative stress responses. Ovchinnikov DA; Withey SL; Leeson HC; Lei UW; Sundarrajan A; Junday K; Pewarchuk M; Yeo AJ; Kijas AW; Lavin MF; Wolvetang EJ Hum Mol Genet; 2020 Apr; 29(6):990-1001. PubMed ID: 32037450 [TBL] [Abstract][Full Text] [Related]
17. Oxidative stress in ataxia telangiectasia. Watters DJ Redox Rep; 2003; 8(1):23-9. PubMed ID: 12631440 [TBL] [Abstract][Full Text] [Related]
18. RYBP Sensitizes Cancer Cells to PARP Inhibitors by Regulating ATM Activity. Maybee DV; Psaras AM; Brooks TA; Ali MAM Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233063 [TBL] [Abstract][Full Text] [Related]
19. The inhibition of poly(ADP-ribose) polymerase enhances growth rates of ataxia telangiectasia cells. Marecki JC; McCord JM Arch Biochem Biophys; 2002 Jun; 402(2):227-34. PubMed ID: 12051667 [TBL] [Abstract][Full Text] [Related]
20. Phenotypic Analysis of ATM Protein Kinase in DNA Double-Strand Break Formation and Repair. Mian E; Wiesmüller L Methods Mol Biol; 2017; 1599():317-334. PubMed ID: 28477129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]